Table 1.
Patient | Gender | Previous Regimen No | Salvage Chemotherapy | Esomeprazole | Cycles | Objective Response |
---|---|---|---|---|---|---|
Case 1 | Male | 1 | Irinotecan | 120 mg, for 2 days | 3 | PD |
Case 2 | Male | 2 | Docetaxel | 120 mg, for 2 days | 2 | SD |
Case 3 | Male | 1 | Irinotecan | 120 mg, for 2 days | 3 | PD |
Case 4 | Male | 1 | Docetaxel | 120 mg, for 2 days | 9 | SD |
Case 5 | Female | 1 | Docetaxel | 120 mg, for 2 days | 6 | SD |
Case 6 | Male | 2 | Irinotecan | 60 mg, for 6 days | 5 | PR |
Case 7 | Male | 1 | 5FU/LV+Oxaliplatin | 60 mg, for 6 days | 5 | PR |